share_log

Shareholder Alert: Ademi LLP Investigates Whether Deciphera Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With ONO Pharmaceutical Co.

Shareholder Alert: Ademi LLP Investigates Whether Deciphera Pharmaceuticals, Inc. Has Obtained a Fair Price in Its Transaction With ONO Pharmaceutical Co.

股東提醒:Ademi LLP正在調查Deciphera Pharmaceuticals, Inc. 在與小野製藥公司的交易中是否獲得了公平的價格。
PR Newswire ·  04/29 10:30

MILWAUKEE, April 29, 2024 /PRNewswire/ -- Ademi LLP is investigating Deciphera (NASDAQ: DCPH) for possible breaches of fiduciary duty and other violations of law in its transaction with ONO.

密爾沃基,2024年4月29日 /PRNewswire/ — Ademi LLP正在調查Deciphera(納斯達克股票代碼:DCPH)在與ONO的交易中可能違反信託義務和其他違法行爲

Click here to learn how to join the or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

點擊此處了解如何加入或撥打 Guri Ademi 的免費電話 866-264-3995。您無需支付任何費用或承擔任何義務。

In the transaction, Deciphera stockholders will receive only $25.60 per share in cash through a tender offer followed by a merger of Deciphera with a wholly-owned subsidiary of ONO, for a total equity value of $2.4 billion. The transaction agreement unreasonably limits competing transactions for Deciphera by imposing a significant penalty if Deciphera accepts a competing bid. Deciphera insiders will receive substantial benefits as part of change of control arrangements.

在這筆交易中,Deciphera的股東將通過要約獲得每股25.60美元的現金,隨後Deciphera與ONO的全資子公司合併,總股權價值爲24億美元。該交易協議不合理地限制了Deciphera的競爭交易,如果Deciphera接受競爭性出價,將處以巨額罰款。作爲控制權變更安排的一部分,Deciphera內部人士將獲得可觀的收益。

We are investigating the conduct of Deciphera's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

我們正在調查Deciphera董事會的行爲,以及他們是否履行了對所有股東的信託責任。

If you own Deciphera common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or

如果你擁有Deciphera普通股並希望獲得更多信息,請致電 [email protected] 或免費電話:866-264-3995 與 Guri Ademi 聯繫,或

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

我們專門處理涉及收購、合併和全國各地個人股東權利的股東訴訟。欲了解更多信息,請隨時致電我們。律師廣告。先前的結果並不能保證類似的結果。

Contacts

聯繫人

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Ademi LLP
Guri Ademi
免費電話:(866) 264-3995
傳真:(414) 482-8001

SOURCE Ademi LLP

來源 Ademi LLP

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論